InhaleRx Limited ( (AU:IRX)) has provided an update. InhaleRx has closed its pro-rata non-renounceable entitlement offer, raising $107,730 before costs from applications for 4.3 million new shares and ...

The latest announcement is out from InhaleRx Limited ( (AU:IRX)). InhaleRx Limited has called a virtual general meeting of shareholders for 29 January 2026 to consider a series of capital-raising ...

It is developing IRX-211 that has completed Phase 1 clinical trial for the treatment of Breakthrough Cancer Pain (BTcP); and IRX-616a that is in preclinical trial for panic disorder (PD). The company ...

Find the latest information on 13 WEEK TREASURY BILL (^IRX) including data, charts, related news and more from Yahoo Finance ...

IRX | A complete CBOE 13 Week Treasury Bill Yield Index index overview by MarketWatch. View stock market news, stock market data and trading information.

CBOE 13 Week Treasury Bill Yield Index advanced index charts by MarketWatch. View real-time IRX index data and compare to other exchanges and stocks.

At close: 24 December at 1:19:35 pm AEDT ...

Get the basic 13 WEEK TREASURY BILL (^IRX) option chain and pricing options for different maturity periods from Yahoo Finance.

InhaleRx Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. It is developing IRX-211 that has completed Phase 1 clinical trial for the ...

Discover historical prices for IRX.AX stock on Yahoo Finance. View daily, weekly or monthly format back to when InhaleRx Limited stock was issued.